Aspira women's health to participate in corporate access events during jp morgan healthcare conference week 2024

Austin, texas, dec. 14, 2023 (globe newswire) -- aspira women's health inc. (“aspira” or “the company”) (nasdaq: awh), a bio-analytical based women's health company focused on the development of gynecologic disease diagnostic tools, today announced that management will be available for partnering and institutional one-on-one meetings in san francisco, during jp morgan's healthcare conference week 2024. nicole sandford, president and chief executive officer, in addition to torsten hombeck, ph.d., chief financial officer from the management team will be in attendance at the following corporate access and partnering events:
AWH Ratings Summary
AWH Quant Ranking